Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Pregnancy complications and metabolic disease in women with clomiphene citrate-resistant anovulation randomized to receive laparoscopic electrocautery of the ovaries or ovulation induction with gonadotropins: a 10-year follow-up.

Nahuis MJ, Oude Lohuis EJ, Bayram N, Hompes PG, Oosterhuis GJ, van der Veen F, Mol BW, van Wely M.

Fertil Steril. 2014 Jan;101(1):270-4. doi: 10.1016/j.fertnstert.2013.09.004.

PMID:
24268702
2.

Long-term follow-up of laparoscopic electrocautery of the ovaries versus ovulation induction with recombinant FSH in clomiphene citrate-resistant women with polycystic ovary syndrome: an economic evaluation.

Nahuis MJ, Oude Lohuis E, Kose N, Bayram N, Hompes P, Oosterhuis GJ, Kaaijk EM, Cohlen BJ, Bossuyt PP, van der Veen F, Mol BW, van Wely M.

Hum Reprod. 2012 Dec;27(12):3577-82. doi: 10.1093/humrep/des336.

PMID:
23001778
3.

Long-term outcomes in women with polycystic ovary syndrome initially randomized to receive laparoscopic electrocautery of the ovaries or ovulation induction with gonadotrophins.

Nahuis MJ, Kose N, Bayram N, van Dessel HJ, Braat DD, Hamilton CJ, Hompes PG, Bossuyt PM, Mol BW, van der Veen F, van Wely M.

Hum Reprod. 2011 Jul;26(7):1899-904. doi: 10.1093/humrep/der141.

PMID:
21576081
6.
7.
8.

Treatment preferences and trade-offs for ovulation induction in clomiphene citrate-resistant patients with polycystic ovary syndrome.

Bayram N, van Wely M, van der Veen F, Bossuyt PM, Nieuwkerk P.

Fertil Steril. 2005 Aug;84(2):420-5. Erratum in: Fertil Steril. 2005 Nov;84(5):1557. Nieuwkerk, Pythia [added].

PMID:
16084884
12.

A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate-resistant polycystic ovary syndrome.

Farquhar CM, Williamson K, Gudex G, Johnson NP, Garland J, Sadler L.

Fertil Steril. 2002 Aug;78(2):404-11.

PMID:
12137881
13.

Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial.

Palomba S, Falbo A, Battista L, Russo T, Venturella R, Tolino A, Orio F, Zullo F.

Am J Obstet Gynecol. 2010 Jun;202(6):577.e1-8. doi: 10.1016/j.ajog.2009.11.042.

PMID:
20096821
14.
15.
16.

The M-OVIN study: does switching treatment to FSH and / or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trial.

Nahuis MJ, Weiss NS, van der Veen F, Mol BW, Hompes PG, Oosterhuis J, Lambalk NB, Smeenk JM, Koks CA, van Golde RJ, Laven JS, Cohlen BJ, Fleischer K, Goverde AJ, Gerards MH, Klijn NF, Nekrui LC, van Rooij IA, Hoozemans DA, van Wely M.

BMC Womens Health. 2013 Oct 25;13:42. doi: 10.1186/1472-6874-13-42.

17.
18.
20.

Are laparoscopic ovarian diathermy and gonadotropin administration the only therapeutic second-steps in clomiphene-citrate resistant women with polycystic ovary syndrome?

Palomba S, Orio F Jr, Falbo A, Russo T, Lombardi G, Zullo F.

Hum Reprod. 2004 Nov;19(11):2682-3; author reply 2683. No abstract available.

PMID:
15496601

Supplemental Content

Support Center